R-019
Retigabine-D4 solution
100 μg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C16H14D4FN3O2
分子量:
307.36
NACRES:
NA.24
UNSPSC Code:
41116107
EC Number:
200-835-2
InChI key
PCOBBVZJEWWZFR-LNFUJOGGSA-N
InChI
1S/C16H18FN3O2/c1-2-22-16(21)20-15-8-7-13(9-14(15)18)19-10-11-3-5-12(17)6-4-11/h3-9,19H,2,10,18H2,1H3,(H,20,21)/i3D,4D,5D,6D
SMILES string
FC1=C([2H])C([2H])=C(CNC2=CC(N)=C(NC(OCC)=O)C=C2)C([2H])=C1[2H]
grade
certified reference material
form
liquid
feature
(Snap-N-Spike®)
packaging
ampule of 1 mL
manufacturer/tradename
Cerilliant®
concentration
100 μg/mL in acetonitrile
technique(s)
gas chromatography (GC): suitable, liquid chromatography (LC): suitable
application(s)
clinical testing
format
single component solution
storage temp.
−20°C
General description
An internal standard and Certified Spiking Solution® suitable for quantitation of retigabine levels in urine or other matrices by LC/MS or GC/MS for testing applications in clinical toxicology, forensic analysis, urine drug testing, medication monitoring, or pharmaceutical research. Retigabine, also known as ezogabine, is a new antiepileptic drug developed for treatment of partial seizures. The drug is marketed under the trade names Potiga® in the US and Trobalt in the EU.
Legal Information
CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation
Potiga is a registered trademark of Valeant Pharmaceuticals North America LLC
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany
signalword
Danger
Hazard Classifications
Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Flam. Liq. 2
存储类别
3 - Flammable liquids
wgk
WGK 2
flash_point_f
42.8 °F - closed cup - Solvent
flash_point_c
6.0 °C - closed cup - Solvent
法规信息
危险化学品
此项目有
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持